Statistical method for pooling categorical biomarkers from multi-center matched/nested case-control studies
Yujie Wu, Xiao Wu, Mitchell H. Gail, Regina G. Ziegler, Stephanie A. Smith-Warner, Molin Wang*, ¡aurhor name¿, ¡aurhor name¿, ¡aurhor name¿, ¡aurhor name¿, ¡aurhor name¿ · 2025
Read Statistical method for pooling categorical biomarkers from multi-center matched/nested case-control studies by Yujie Wu, Xiao Wu, Mitchell H. Gail, Regina G. Ziegler, Stephanie A. Smith-Warner, Molin Wang*, ¡aurhor name¿, ¡aurhor name¿, ¡aurhor name¿, ¡aurhor name¿, ¡aurhor name¿ (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2505-02220.txt.
Introduction
Pooling health studies boosts power, but each lab's biomarker reads carry its own slant. Yujie Wu and co-authors give a pooling method that corrects that slant in a 2025 paper. Their setting is matched case-control studies with grouped biomarker levels.
A likelihood method folds each study's calibration step into the pooled fit. A sandwich estimator then gives honest error bars for the pooled effects. Simulations across sample sizes show the method behaves well. The team applies it to a vitamin D and colon cancer pooling project. The recipe lets groups merge data without pretending the labs agreed.
Catalog record
| CREATOR | Yujie Wu, Xiao Wu, Mitchell H. Gail, Regina G. Ziegler, Stephanie A. Smith-Warner, Molin Wang*, ¡aurhor name¿, ¡aurhor name¿, ¡aurhor name¿, ¡aurhor name¿, ¡aurhor name¿ |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| VERSION | 1.0 |
| LICENSE | http://creativecommons.org/licenses/by/4.0/ |
| RIGHTS | CC BY |
| SOURCE | arXiv |
Source: https://arxiv.org/abs/2505-02220
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Statistical method for pooling categorical biomarkers from multi-center matched/nested case-control studies Yujie Wu, Xiao Wu, Mitchell H. Gail, Regina G. Ziegler, Stephanie A. Smith-Warner, Molin Wang*, ¡aurhor name¿, ¡aurhor name¿, ¡aurhor name¿, ¡aurhor name¿, ¡aurhor name¿ Abstract Pooled analyses that aggregate data from multiple studies are becoming increasingly common in collaborative epidemiologic research in order to increase the size and diversity of the study population. However, biomarker measurements from different studies are subject to systematic measurement errors and directly pooling them for analyses may lead to biased estimates of the regression parameters. Therefore, study-specific calibration processes must be incorporated in the statistical analyses to address between-study/assay/laboratory variability in the biomarker measurements. We propose a likelihood-based method to evaluate biomarker-disease relationships for categorical biomarkers in matched/nested case-control studies. To account for the additional uncertainties from the calibration processes, we propose a sandwich variance estimator to obtain valid asymptotic variances of the estimated regression parameters. Extensive simulation studies with varying sample sizes and biomarker-disease associations are used to evaluate the finite sample performance of our proposed methods. As an illustration, we apply the methods to a vitamin D pooling project of colorectal cancer to evaluate the effect of categorical vitamin D levels on colorectal cancer risks. Publication type: RESEARCH ARTICLE keywords Calibration, Conditional Likelihood, Matched Case-control Study, Measurement Error, Nested Case-control Study, Pooling Project † † corresponding: *Molin Wang, Departments of Biostatistics and Epidemiology, Harvard T. H. Chan School of Public Health, and Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115. † † citation: ), , ¡year¿ ¡vol¿ Page ¡xxx¿-¡xxx¿ † † copyright: , , , , and ( † † year: ¡year¿ † † ctitle: ¡journal title¿ † † cjournal: ¡journal name¿ Wu et al 1 Introduction Studies aiming to investigate biomarker-disease relationships often suffer from small sample sizes, and one way to increase sample sizes, as well as diversity in the study population, is to combine data from multiple studies. Pooling data from multiple studies can also enable potential examination of population subgroups and disease subtypes due to increased sample sizes [ 1 , 2 , 3 ] . There are two common approaches to analyzing combined participant-level data from multiple studies: the two-stage method and the aggregated data method. The first stage of the two-stage method obtains study-specific exposure-disease associations, and in the second stage, a pooled estimate of the association is calculated by using meta-analytic techniques [ 2 ] . On the other hand, the aggregated data method performs a one-stage analysis on the pooled dataset that includes observations from all individual studies. One drawback of the two-stage method is that, in subset analyses or under rare outcome situations, data may become so sparse that some individual studies have no cases, or no controls, in some exposure categories, making the estimation of some coefficients difficult [ 4 ] . In contrast, the aggregated data method is less likely to encounter these data sparsity issues and allows more modelling flexibility [ 5 ] . In this paper, we focus on developing methods for the aggregated data analysis using participant-level data. A major challenge in the analysis of pooled biomarker data is potential systematic differences in biomarker measurements among studies using different laboratories. Ignoring this between-assay/laboratory variability may lead to biased association estimates [ 4 , 6 ] . For example, the Circulating Biomarkers and Breast and Colorectal Cancer Consortium (BBC3) was established to assess the associations between vitamin D, as measured by circulating concentrations of 25-hydroxyvitamin D [25(OH)D], the accepted measure of vitamin D status, and breast and colorectal cancer risk. The BBC3 consists of a total of 17 breast cancer nested case-control studies and 17 CRC nested case-control studies with 25(OH)D concentrations measured in different local laboratories, often using different assay methodologies, and the 25(OH)D measurements can vary up to 40% across different laboratories and assays [ 7 ] . To address between-study variability in the biomarker measurements across studies, a study-specific calibration process needs to be incorporated. This calibration process often relies on a designated reference laboratory, which uses a widely accepted, valid assay method. Representative subsets of the samples from each study are re-assayed in the reference laboratory, and we refer to these subsets as calibration subsets. In these calibration subsets, we can fit study-specific calibration models relating the reference laboratory measurements to the local laboratory measurements. Based on these calibration models, the reference laboratory measurements can be imputed for all study participants. Ideally, the calibration study samples should be selected at random from the entire study cohort. However, due to potential concerns about the availability of biomarker measurements in cases, investigators typically only select controls into the calibration studies [ 6 ] . In our motivating BBC3 study, researchers were particularly interested in the relationship between breast and colorectal cancer risk and circulating 25(OH)D which were categorized based on the Institute of Medicine (IOM), now named the National Academy of Medicine, recommended guidance: deficiency ( <30 nmol/L), insufficiency ( [30,50) nmol/L), sufficiency and beyond sufficiency ( \geq 50 nmol/L) [ 7 ] . Circulating 25(OH)D measurements were obtained from a variety of local laboratories in the studies and thus their concentrations may not be directly comparable on an absolute scale. Therefore, 29 controls from each nested case-control study were sampled to have their blood samples re-assayed in the reference laboratory. Sloan et al. (2019) presents methods for pooling biomarker data when the biomarker is treated as a continuous variable in statistical analyses [ 6 ] . Here, we consider developing methods to pool categorical biomarkers. The usual analysis of categorical biomarker measurements proceeds by first fitting a regression calibration model to calibrate the continuous local laboratory measurements, and then discretizing the calibrated continuous biomarker measurements for categorical analysis [ 8 ] . In this paper, we consider an alternative approach that directly obtains the calibrated categorical biomarkers through a multinomial logistic regression, and we propose a joint likelihood approach for inferences on the association between categorical biomarker measurements and disease risks . The proposed methods eliminate the bias in the effect estimates due to between-study/assay/laboratory variability in the biomarker measurements, and account for the additional uncertainties introduced by the calibration processes for inference. The paper is organized as follows. In Section 2, we introduce the methods; in Section 3, we perform simulation studies to evaluate our methods in finite sample sizes; Section 4 presents the real data application, evaluating the effect of categorical circulating 25(OH)D concentrations on colorectal cancer risk, and Section 5 concludes the paper. 2 Methods 2.1 Notations and Models Let Y denote the binary disease outcome, X denote the continuous biomarker measurement from the reference laboratory, W denote the continuous biomarker measurement from study-specific local laboratories, and \mathbf{Z} be a column vector of other covariates. Assume there are S matched/nested case-control studies, and the s -th study consists of N_{s} strata, with one case and M_{sj} matched controls in the j -th stratum, j=1,\ldots,N_{s} , s=1,\ldots,S . For notational simplicity, we assume there is only one case in each stratum. The method can be straightforwardly extended to designs with multiple cases in some or all strata. We assume the following conditional logistic